Blue Earth Diagnostics

📍 Oxford, United Kingdom🗓 Founded 2014👥 95 employees💰 Last funded Mar 2014
Pharmaceutical Manufacturing🌐 blueearthdiagnostics.com
Website LinkedIn
Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A., is a growing international molecular imaging company focused on delivering innovative, well-differentiated diagnostic solutions that inform patient care. Formed in 2014, the Company’s success is driven by its management expertise and supported by a demonstrated track record of rapid development and commercialization of positron emission tomography (PET) radiopharmaceuticals. Blue Earth Diagnostics’ expanding oncology portfolio encompasses a variety of disease states, including prostate cancer and neuro-oncology. Blue Earth Diagnostics is committed to the timely development and commercialization of precision radiopharmaceuticals for potential use in imaging and therapy.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Blue Earth Diagnostics?
Blue Earth Diagnostics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Blue Earth Diagnostics last raise funding?
The most recent investment in Blue Earth Diagnostics recorded on gritt.io was in March 2014.
When was Blue Earth Diagnostics founded?
Blue Earth Diagnostics was founded in 2014.
What industry is Blue Earth Diagnostics in?
Blue Earth Diagnostics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Blue Earth Diagnostics based?
Blue Earth Diagnostics is headquartered in Oxford, United Kingdom.